About Us-2 - StoneWise AI

AI-driven Novel Drug Discovery and Development

Leveraging industry expertise, breakthroughs in AI technology, in-depth data governance capabilities, and robust software and hardware capabilities, the company has developed a multimodal AI 3D generation model focused on small molecules.

Text

Jielong Zhou - Founder & CEO

Have carried out various forms of cooperation with hundreds of domestic

and overseas pharmaceutical enterprises

Have completed several rounds of financing, with a total of over 100 million US dollars

Have established close cooperation with multiple leading domestic

and overseas cloud computing power vendors

Contact Us

Start Your Intelligent Drug Design Journey

MolVado Small Molecule Drug Design Platform – Empowering Your R&D Breakthroughs

产品&服务

StoneWise (HK) Limited

BD Inquiries: bd@stonewise.cn

Customer Service: support@stonewise.cn

Investment Inquiries: ir@stonewise.cn

Media Inquiries: pr@stonewise.cn

Address (Beijing): 10th Floor, Block A, Sinosteel Plaza, No. 8 Haidian Street, Haidian District, Beijing

Address (Shanghai): A3018, No. 1077 Zhang Heng Road, Pudong New Area, Shanghai

StoneWise (HK) Limited

BD Inquiries: bd@stonewise.cn

Customer Service: support@stonewise.cn

Investment Inquiries: ir@stonewise.cn

Media Inquiries: pr@stonewise.cn

Address (Beijing): 10th Floor, Block A, Sinosteel Plaza, No. 8 Haidian Street, Haidian District, Beijing

Address (Shanghai): A3018, No. 1077 Zhang Heng Road, Pudong New Area, Shanghai